(Insulin-Like Growth Factor-1 Long Arg3 | Extended-Action Anabolic Peptide)
IGF-1 LR3 is a long-acting recombinant analogue of native IGF-1 β engineered for 3Γ stronger receptor activity, minimal binding-protein interference, and significantly enhanced anabolic, regenerative, and metabolic signaling.
𧬠What Is IGF-1 LR3?
IGF-1 LR3 (Long Arg3 IGF-1) is an 83βamino-acid modified form of human IGF-1 with:
β’ A 13βamino-acid N-terminal extension β’ A Glutamic Acid β Arginine substitution at position 3 β’ Greatly reduced affinity for IGF binding proteins (IGFBPs) β’ ~20β30 hour half-life (vs ~15 minutes for native IGF-1)
Researchers study IGF-1 LR3 for:
β’ PI3K/Akt + MAPK pathway activation β’ Muscle cell hyperplasia & nutrient uptake β’ Protein synthesis & nitrogen retention β’ Accelerated tendon, nerve, and muscle repair β’ Improved glucose disposal & metabolic modulation β’ Vascular smooth-muscle support
π¦ Product Breakdown β Paramount Peptides
β’ IGF-1 LR3 (1mg) HERE β’ Recombinant long-acting IGF analogue β’ High-purity anabolic research peptide β’ π Use code BHGUIDE for discount
π Reconstitution Instructions Table (1mg IGF-1 LR3)
Step Details Sanitize Clean vial stoppers & workspace Add BAC Water Inject 1β2mL slowly down vial wall Dissolve Swirl gently β do not shake Final Conc. 1mg Γ· added mL Syringe U-100 insulin syringe Storage Refrigerate 2β8Β°C (~30 days)
Example: β’ 1mg + 1mL = 1mg/mL β’ 1mg + 2mL = 0.5mg/mL
π Dosing & Protocol Table (for research purposes only)
Goal Typical Research Dose Frequency Notes Muscle Cell Studies 20β50mcg 1Γ daily Strong anabolic signaling Tissue Regeneration 50β100mcg 1Γ daily Used in nerve, tendon, muscle models Performance & Hypertrophy 50β120mcg 1Γ daily Paired with resistance training Fat-Loss + Recomp 20β50mcg 1Γ daily Improved nutrient partitioning Localized Studies 20β40mcg site-specific 1Γ daily Localized protocols are common
Protocol Notes: β’ Long-acting LR3 β once-daily dosing is standard β’ Avoid combining with insulin (hypoglycemia risk) β’ LR3 is extremely potent β higher doses rarely needed
𧬠What to Expect Timeline
Timeline Common Research Observations Week 1β2 Improved pumps, glucose uptake, faster recovery Week 3β4 Noticeable performance changes, early recomposition Week 4β8 Strong nutrient partitioning, muscle hardness, tissue repair 8β12+ wk Peak performance, deep regeneration-marker changes
π Researcher Notes (Important)
β’ LR3 binds receptors 3Γ stronger than native IGF-1 β’ Low IGFBP binding β more active circulating IGF-1 β’ Activates satellite-cell pathways β’ Enhances amino-acid + glucose uptake β’ Strong synergy with training stimulus β’ Often paired with: β CJC-1295 No DAC β GH fragments (AOD-9604) β BPC-157 for recovery
π§ͺ What Youβll Need (Checklist)
β’ IGF-1 LR3 vial HERE β’ Bacteriostatic Water HERE β’ 29β31g U-100 insulin syringes β’ Alcohol pads β’ Sharps container β’ Peptide Calculator
π Quick Links
β’ BHGUIDE β’ Bacteriostatic Water β’ Peptide Calculator
β οΈ Disclaimer For research and educational purposes only. Not medical advice. Not for human consumption.